blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2739260

EP2739260 - USE OF CANNABINOID COMPOUNDS FOR STIMULATING MELANOGENESIS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  03.08.2018
Database last updated on 31.08.2024
FormerThe patent has been granted
Status updated on  25.08.2017
FormerGrant of patent is intended
Status updated on  25.04.2017
FormerExamination is in progress
Status updated on  21.11.2016
Most recent event   Tooltip17.07.2020Lapse of the patent in a contracting state
New state(s): AL		published on 19.08.2020  [2020/34]
Applicant(s)For all designated states
L'OREAL
14 rue Royale
75008 Paris / FR
[2014/24]
Inventor(s)01 / ZUCCOLO, Michela
3 Villa Gaudelet
F-75011 Paris / FR
02 / JOURDAIN, Roland
8 rue Georges Millandy
F-92360 Meudon La Forêt / FR
03 / BRETON, Lionel
20 avenue de Paris
F-78000 Versailles / FR
04 / MACCARRONE, Mauro
Via San Sisto n° 87
I-67100 L'aquila / IT
 [2014/24]
Representative(s)Pillet, Anne-Helene, et al
L'Oréal
Service DIPI
9 Rue Pierre Dreyfus
92110 Clichy / FR
[2017/39]
Former [2014/24]Touroude-Barbot, Magali Linda
L'OREAL
D.I.P.I.
25-29 Quai Aulagnier
92665 Asnieres-sur-Seine Cedex / FR
Application number, filing date12750477.703.08.2012
[2017/39]
WO2012FR51846
Priority number, dateFR2011005721305.08.2011         Original published format: FR 1157213
[2014/24]
Filing languageFR
Procedural languageFR
PublicationType: A2 Application without search report
No.:WO2013021128
Date:14.02.2013
Language:FR
[2013/07]
Type: A2 Application without search report 
No.:EP2739260
Date:11.06.2014
Language:FR
The application published by WIPO in one of the EPO official languages on 14.02.2013 takes the place of the publication of the European patent application.
[2014/24]
Type: B1 Patent specification 
No.:EP2739260
Date:27.09.2017
Language:FR
[2017/39]
Search report(s)International search report - published on:EP08.08.2013
ClassificationIPC:A61K8/42, A61Q5/10, A61Q19/04, A61K31/164, A61P17/00
[2014/24]
CPC:
A61K8/42 (EP,US); A61K31/16 (EP,US); A61K31/164 (EP,US);
A61P17/00 (EP); A61Q19/00 (US); A61Q19/04 (EP,US);
A61Q5/00 (US); A61Q5/10 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2014/24]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:VERWENDUNG VON CANNABINOIDVERBINDUNGEN ZUR FÖRDERUNG VON MELANOGENESE[2014/24]
English:USE OF CANNABINOID COMPOUNDS FOR STIMULATING MELANOGENESIS[2014/24]
French:UTILISATION DE COMPOSÉS CANNABINOÏDES POUR STIMULER LA MÉLANOGÉNÈSE[2014/24]
Entry into regional phase05.03.2014National basic fee paid 
05.03.2014Designation fee(s) paid 
05.03.2014Examination fee paid 
Examination procedure05.03.2014Examination requested  [2014/24]
15.09.2014Amendment by applicant (claims and/or description)
14.09.2016Despatch of a communication from the examining division (Time limit: M02)
21.11.2016Reply to a communication from the examining division
26.04.2017Communication of intention to grant the patent
16.08.2017Fee for grant paid
16.08.2017Fee for publishing/printing paid
16.08.2017Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  14.09.2016
Opposition(s)28.06.2018No opposition filed within time limit [2018/36]
Fees paidRenewal fee
13.08.2014Renewal fee patent year 03
10.08.2015Renewal fee patent year 04
11.08.2016Renewal fee patent year 05
14.08.2017Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU03.08.2012
AL27.09.2017
AT27.09.2017
CY27.09.2017
CZ27.09.2017
DK27.09.2017
EE27.09.2017
ES27.09.2017
FI27.09.2017
GR27.09.2017
HR27.09.2017
IT27.09.2017
LT27.09.2017
LV27.09.2017
MC27.09.2017
MK27.09.2017
MT27.09.2017
NL27.09.2017
PL27.09.2017
PT27.09.2017
RO27.09.2017
RS27.09.2017
SE27.09.2017
SI27.09.2017
SK27.09.2017
SM27.09.2017
TR27.09.2017
BG27.12.2017
NO27.12.2017
IS27.01.2018
[2020/34]
Former [2020/31]HU03.08.2012
AT27.09.2017
CY27.09.2017
CZ27.09.2017
DK27.09.2017
EE27.09.2017
ES27.09.2017
FI27.09.2017
GR27.09.2017
HR27.09.2017
IT27.09.2017
LT27.09.2017
LV27.09.2017
MC27.09.2017
MK27.09.2017
MT27.09.2017
NL27.09.2017
PL27.09.2017
PT27.09.2017
RO27.09.2017
RS27.09.2017
SE27.09.2017
SI27.09.2017
SK27.09.2017
SM27.09.2017
TR27.09.2017
BG27.12.2017
NO27.12.2017
IS27.01.2018
Former [2020/30]HU03.08.2012
AT27.09.2017
CZ27.09.2017
DK27.09.2017
EE27.09.2017
ES27.09.2017
FI27.09.2017
GR27.09.2017
HR27.09.2017
IT27.09.2017
LT27.09.2017
LV27.09.2017
MC27.09.2017
MT27.09.2017
NL27.09.2017
PL27.09.2017
PT27.09.2017
RO27.09.2017
RS27.09.2017
SE27.09.2017
SI27.09.2017
SK27.09.2017
SM27.09.2017
TR27.09.2017
BG27.12.2017
NO27.12.2017
IS27.01.2018
Former [2020/28]HU03.08.2012
AT27.09.2017
CZ27.09.2017
DK27.09.2017
EE27.09.2017
ES27.09.2017
FI27.09.2017
HR27.09.2017
IT27.09.2017
LT27.09.2017
LV27.09.2017
MC27.09.2017
MT27.09.2017
NL27.09.2017
PL27.09.2017
PT27.09.2017
RO27.09.2017
RS27.09.2017
SE27.09.2017
SI27.09.2017
SK27.09.2017
SM27.09.2017
TR27.09.2017
BG27.12.2017
NO27.12.2017
IS27.01.2018
Former [2020/16]AT27.09.2017
CZ27.09.2017
DK27.09.2017
EE27.09.2017
ES27.09.2017
FI27.09.2017
HR27.09.2017
IT27.09.2017
LT27.09.2017
LV27.09.2017
MC27.09.2017
MT27.09.2017
NL27.09.2017
PL27.09.2017
RO27.09.2017
RS27.09.2017
SE27.09.2017
SI27.09.2017
SK27.09.2017
SM27.09.2017
TR27.09.2017
BG27.12.2017
NO27.12.2017
IS27.01.2018
Former [2019/15]AT27.09.2017
CZ27.09.2017
DK27.09.2017
EE27.09.2017
ES27.09.2017
FI27.09.2017
HR27.09.2017
IT27.09.2017
LT27.09.2017
LV27.09.2017
MC27.09.2017
MT27.09.2017
NL27.09.2017
PL27.09.2017
RO27.09.2017
RS27.09.2017
SE27.09.2017
SI27.09.2017
SK27.09.2017
SM27.09.2017
BG27.12.2017
NO27.12.2017
IS27.01.2018
Former [2018/52]AT27.09.2017
CZ27.09.2017
DK27.09.2017
EE27.09.2017
ES27.09.2017
FI27.09.2017
HR27.09.2017
IT27.09.2017
LT27.09.2017
LV27.09.2017
MT27.09.2017
NL27.09.2017
PL27.09.2017
RO27.09.2017
RS27.09.2017
SE27.09.2017
SI27.09.2017
SK27.09.2017
SM27.09.2017
BG27.12.2017
NO27.12.2017
IS27.01.2018
Former [2018/43]AT27.09.2017
CZ27.09.2017
DK27.09.2017
EE27.09.2017
ES27.09.2017
FI27.09.2017
HR27.09.2017
IT27.09.2017
LT27.09.2017
LV27.09.2017
MT27.09.2017
NL27.09.2017
PL27.09.2017
RO27.09.2017
RS27.09.2017
SE27.09.2017
SK27.09.2017
SM27.09.2017
BG27.12.2017
NO27.12.2017
IS27.01.2018
Former [2018/39]AT27.09.2017
CZ27.09.2017
DK27.09.2017
EE27.09.2017
ES27.09.2017
FI27.09.2017
HR27.09.2017
IT27.09.2017
LT27.09.2017
LV27.09.2017
NL27.09.2017
PL27.09.2017
RO27.09.2017
RS27.09.2017
SE27.09.2017
SK27.09.2017
SM27.09.2017
BG27.12.2017
NO27.12.2017
IS27.01.2018
Former [2018/35]AT27.09.2017
CZ27.09.2017
DK27.09.2017
EE27.09.2017
ES27.09.2017
FI27.09.2017
HR27.09.2017
IT27.09.2017
LT27.09.2017
LV27.09.2017
NL27.09.2017
RO27.09.2017
RS27.09.2017
SE27.09.2017
SK27.09.2017
SM27.09.2017
BG27.12.2017
NO27.12.2017
IS27.01.2018
Former [2018/24]AT27.09.2017
CZ27.09.2017
EE27.09.2017
ES27.09.2017
FI27.09.2017
HR27.09.2017
IT27.09.2017
LT27.09.2017
LV27.09.2017
NL27.09.2017
RO27.09.2017
RS27.09.2017
SE27.09.2017
SK27.09.2017
SM27.09.2017
BG27.12.2017
NO27.12.2017
IS27.01.2018
Former [2018/23]AT27.09.2017
CZ27.09.2017
EE27.09.2017
ES27.09.2017
FI27.09.2017
HR27.09.2017
LT27.09.2017
LV27.09.2017
NL27.09.2017
RO27.09.2017
RS27.09.2017
SE27.09.2017
SK27.09.2017
BG27.12.2017
NO27.12.2017
IS27.01.2018
Former [2018/21]CZ27.09.2017
FI27.09.2017
HR27.09.2017
LT27.09.2017
LV27.09.2017
NL27.09.2017
RS27.09.2017
SE27.09.2017
BG27.12.2017
NO27.12.2017
Former [2018/15]FI27.09.2017
HR27.09.2017
LT27.09.2017
LV27.09.2017
NL27.09.2017
RS27.09.2017
SE27.09.2017
BG27.12.2017
NO27.12.2017
Former [2018/13]FI27.09.2017
HR27.09.2017
LT27.09.2017
LV27.09.2017
RS27.09.2017
SE27.09.2017
BG27.12.2017
NO27.12.2017
Former [2018/11]FI27.09.2017
HR27.09.2017
LT27.09.2017
RS27.09.2017
SE27.09.2017
BG27.12.2017
NO27.12.2017
Former [2018/10]FI27.09.2017
HR27.09.2017
LT27.09.2017
RS27.09.2017
SE27.09.2017
NO27.12.2017
Former [2018/08]FI27.09.2017
LT27.09.2017
NO27.12.2017
Former [2018/07]LT27.09.2017
NO27.12.2017
Cited inInternational search[I]WO2006024958  (NOVIMMUNE SA [CH], et al) [I] 7 * page 2, line 9 - page 2, line 24 *;
 [AD]WO9511003  (PHARMACIA AB [SE], et al) [AD] 1-10 * page 1, paragraph 1 * * page 5, line 9 - page 5, line 19 * * page 5, line 32 - page 5, line 38 *;
 [A]EP0355842  (SANSHO SEIYAKU KK [JP]) [A] 1-10 * abstract * * page 2, line 46 - page 3, line 12 * * page 18, line 28 - page 18, line 29 *;
 [A]WO2009071422  (UNILEVER PLC [GB], et al) [A] 1-10 * the whole document *;
 [AD]WO2009158499  (UNIV NORTH TEXAS [US], et al) [AD] 1-10 * the whole document *;
 [A]FR2848106  (OREAL [FR]) [A] 1-10 * page 2, line 30 - page 2, line 34 * * page 3, line 29 - page 3, line 32 *
    [ ] - CAPLUS, CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US, Database accession no. 1990:557833, XP002675909
 [AD]  - SOFIA MAGINA ET AL, "Inhibition of basal and ultraviolet B-induced melanogenesis by cannabinoid CB1 receptors: a keratinocyte-dependent effect", ARCHIVES OF DERMATOLOGICAL RESEARCH, (20110205), vol. 303, no. 3, doi:10.1007/s00403-011-1126-z, ISSN 0340-3696, pages 201 - 210, XP055026334 [AD] 1-10 * the whole document *

DOI:   http://dx.doi.org/10.1007/s00403-011-1126-z
by applicantWO9517161
 WO9511003
 WO9501773
 WO9404674
 WO9404122
 EP0585018
 WO9310804
 WO9220322
 WO9107945
 WO2009158499
 EP1878790
    - J. MED. CHEM., (2007), vol. 50, pages 3851 - 3856
    - XIAO ET AL., ARCH DERMATOL RES, (2007), vol. 299, pages 245 - 57
    - ENDOCRINOLOGY, (2009), vol. 150, pages 4692 - 4700
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.